Monsanto rejects Bayer buyout, again

SHARE Monsanto rejects Bayer buyout, again

NEW YORK — Monsanto on Tuesday rejected a second and richer takeover bid from Bayer.

The German drug and chemicals company last week boosted its offer from $62 billion to about $65 billion, or $125 per share.

Monsanto Co., a seed company, called the revised offer inadequate, as it did the initial bid.

The St. Louis company said that it remains open to talks with Bayer and others about a deal.

Bayer on Tuesday said that it was disappointed with the second rejection, and took a shot at the company in a written statement.

“The revised all-cash offer is a compelling opportunity and represents immediate and certain value for Monsanto shareholders amid recent weak business performance and Monsanto’s reduced mid-term outlook,” Bayer said.

It said it looked forward to further negotiations.

The Latest
The siblings have very different views, and their visits are wonderful until one brings up a certain candidate.
The Bulls’ “Big Three” of Zach LaVine, DeMar DeRozan and Nikola Vucevic overcame Damian Lillard’s 40 points and turned things around in the second half. But with just two games left before Thursday’s trade deadline, will the win give the front office any clarity?
“Jane’s testimony was not truthful when she claimed she was ‘undecided’ about whether she would seek restitution from the Defendant,” the motions states.
Wife is so fearful of bad news that she’s on the verge of cancelling.